九源基因(02566.HK):建议实行H股全流通
Group 1 - The core point of the article is that Jiuyuan Gene (02566.HK) announced the board's approval for the proposal to implement full circulation of H-shares, converting 136 million unlisted shares held by 12 shareholders into H-shares [1] Group 2 - The conversion of shares is set to take place on December 2, 2025 [1] - The move aims to enhance liquidity and broaden the shareholder base for the company [1] - This decision reflects the company's strategy to optimize its capital structure and improve market accessibility [1]